Catalyst Pharmaceuticals Quarterly Income Statements Chart
Quarterly
|
Annual
Catalyst Pharmaceuticals Quarterly Income Statements Table
Quarterly
|
Annual
Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-12-31 | 2014-09-30 | 2014-06-30 | 2014-03-31 | 2013-12-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 | 2012-12-31 | 2012-09-30 | 2012-06-30 | 2012-03-31 | 2011-12-31 | 2011-09-30 | 2011-06-30 | 2011-03-31 | 2010-12-31 | 2010-09-30 | 2010-06-30 | 2010-03-31 | 2009-12-31 | 2009-09-30 | 2009-06-30 | 2009-03-31 | 2008-12-31 | 2008-09-30 | 2008-06-30 | 2008-03-31 | 2008-01-04 | 2007-12-31 | 2007-09-30 | 2007-06-30 | 2007-03-31 | 2007-01-04 | 2007-01-04 | 2006-12-31 | 2006-09-30 | 2006-01-04 | 2006-01-04 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
revenues: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
product revenue | 146,540,000 | 141,400,000 | 141,809,000 | 126,424,000 | 122,653,000 | 98,441,000 | 109,104,000 | 102,617,000 | 99,477,000 | 85,304,000 | 60,683,000 | 57,173,000 | 53,049,000 | 43,033,000 | 38,266,000 | 35,890,000 | 33,636,000 | 30,205,000 | 30,832,723 | 29,166,658 | 29,604,764 | 29,136,472 | 30,122,555 | 30,897,444 | 28,837,900 | 12,448,438 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
license and other revenue | 23,000 | 21,000 | 11,000 | 2,271,000 | 57,000 | 68,000 | 1,464,000 | 71,000 | 105,000 | 62,000 | 74,000 | 71,000 | 64,000 | 56,000 | 43,000 | 64,000 | 2,729,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total revenues | 146,563,000 | 141,421,000 | 141,820,000 | 128,695,000 | 122,710,000 | 98,509,000 | 110,568,000 | 102,688,000 | 99,582,000 | 85,366,000 | 60,757,000 | 57,244,000 | 53,113,000 | 43,089,000 | 38,309,000 | 35,954,000 | 36,365,000 | 31,014,909 | 29,316,658 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
operating costs and expenses: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cost of sales | 20,614,000 | 17,911,000 | 21,643,000 | 19,277,000 | 15,405,000 | 12,520,000 | 15,809,000 | 14,167,000 | 12,045,000 | 9,946,000 | 11,195,000 | 9,665,000 | 7,643,000 | 5,890,000 | 7,348,000 | 5,310,000 | 4,545,000 | 4,681,000 | 4,869,658 | 3,878,760 | 4,139,873 | 4,150,866 | 4,398,265 | 4,387,461 | 4,261,625 | 1,711,788 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
gross profit | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
yoy | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
qoq | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
gross margin % | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
research and development | 4,358,000 | 3,887,000 | 3,798,000 | 3,284,000 | 2,985,000 | 2,581,000 | 1,972,000 | 83,662,000 | 3,954,000 | 3,562,000 | 4,093,000 | 8,310,000 | 3,983,000 | 3,403,000 | 4,992,000 | 4,487,000 | 4,450,000 | 3,007,000 | 4,175,028 | 3,749,233 | 4,349,643 | 4,222,811 | 6,308,390 | 4,597,039 | 4,629,364 | 3,307,959 | 8,416,969 | 4,538,369 | 3,704,824 | 3,259,042 | 3,404,634 | 2,704,923 | 2,451,751 | 2,813,929 | 2,820,654 | 2,493,999 | 2,508,897 | 3,546,391 | 3,831,611 | 3,042,671 | 2,577,508 | 2,349,552 | 2,384,241 | 2,885,892 | 2,098,958 | 2,748,683 | 30,371,388 | 2,804,352 | 2,132,038 | 1,092,301 | 26,388,400 | 654,837 | 532,741 | 727,327 | 23,219,983 | 614,137 | 905,635 | 903,953 | 20,522,130 | 500,091 | 797,935 | 439,587 | 15,403,079 | 850,998 | 1,376,253 | 2,322,632 | 3,272,359 | 11,583,163 | 9,131,584 | 7,229,440 | 11,583,163 | 722,011 | 5,373,070 | 4,869,722 | 3,866,942 | -2,778,203 | 2,915,883 | ||||
selling, general and administrative | 45,949,000 | 46,911,000 | 44,192,000 | 45,880,000 | 40,730,000 | 46,938,000 | 42,036,000 | 33,560,000 | 28,396,000 | 29,718,000 | 14,668,000 | 14,167,000 | 12,918,000 | 16,430,000 | 13,227,000 | 12,153,000 | 11,532,000 | 12,716,000 | 13,352,387 | 9,984,961 | 10,833,358 | 10,063,048 | 11,409,213 | 8,067,792 | 8,987,722 | 8,416,460 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
amortization of intangible assets | 9,344,000 | 9,345,000 | 9,344,000 | 9,345,000 | 9,344,000 | 9,344,000 | 9,059,000 | 8,487,000 | 8,488,000 | 6,531,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total operating costs and expenses | 80,265,000 | 78,054,000 | 78,977,000 | 77,786,000 | 68,464,000 | 71,383,000 | 68,876,000 | 139,876,000 | 52,883,000 | 49,757,000 | 29,956,000 | 32,142,000 | 24,544,000 | 25,723,000 | 25,567,000 | 21,950,000 | 20,527,000 | 20,404,000 | 22,397,073 | 17,612,954 | 19,322,874 | 18,436,725 | 22,115,868 | 17,052,292 | 17,878,711 | 13,436,207 | 15,343,267 | 8,182,603 | 6,335,855 | 5,933,440 | 5,511,786 | 4,306,708 | 4,181,271 | 4,679,871 | 4,314,199 | 3,914,014 | 4,814,452 | 6,237,536 | 6,191,679 | 5,017,428 | 4,897,330 | 4,291,915 | 3,983,861 | 4,109,029 | 2,990,173 | 3,508,365 | 47,677,519 | 3,245,776 | 2,653,529 | 1,705,430 | 41,254,809 | 1,283,713 | 1,067,364 | 1,364,710 | 35,701,733 | 1,131,010 | 1,397,463 | 1,519,250 | 30,375,308 | 908,465 | 1,333,132 | 1,050,412 | 23,048,509 | 1,292,314 | 1,768,812 | 3,044,543 | 3,791,458 | 18,087,326 | 15,172,548 | 12,708,871 | 18,087,326 | 971,140 | 9,842,270 | 8,891,844 | 7,454,856 | 1,268,139.75 | 5,072,559 | ||||
operating income | 66,298,000 | 63,367,000 | 62,843,000 | 50,909,000 | 54,246,000 | 27,126,000 | 41,692,000 | -37,188,000 | 46,699,000 | 35,609,000 | 30,801,000 | 25,102,000 | 28,569,000 | 17,366,000 | 12,742,000 | 14,004,000 | 15,838,000 | 9,801,000 | 8,617,836 | 11,703,704 | 10,281,890 | 10,699,747 | 8,006,687 | 13,845,152 | 10,959,189 | 3,866,942 | 3,866,942 | 2,915,883 | 2,915,883 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
yoy | 22.22% | 133.60% | 50.73% | -236.90% | 16.16% | -23.82% | 35.36% | -248.15% | 63.46% | 105.05% | 141.73% | 79.25% | 80.38% | 77.19% | 47.86% | 19.65% | 54.04% | -8.40% | 7.63% | -15.47% | -6.18% | 46.96% | 46.96% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
qoq | 4.63% | 0.83% | 23.44% | -6.15% | 99.98% | -34.94% | -212.11% | -179.63% | 31.14% | 15.61% | 22.70% | -12.14% | 64.51% | 36.29% | -9.01% | -11.58% | 61.60% | 13.73% | -26.37% | 13.83% | -3.91% | 33.64% | -42.17% | 26.33% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
operating margin % | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other income | 2,995,000 | 7,919,000 | 11,338,000 | 6,296,000 | 1,542,000 | 1,963,000 | 5,015,000 | -833,000 | 1,813,000 | 1,704,000 | 2,207,000 | 905,000 | -324,000 | 93,000 | 71,000 | 68,000 | 62,000 | 81,000 | 105,828 | 33,567 | 111,269 | 336,233 | 398,683 | 393,415 | 450,410 | 343,266 | 343,658 | 343,730 | 370,715 | 233,548 | 124,088 | 129,059 | 91,039 | 109,977 | 43,933 | 66,981 | 92,755 | 117,943 | -13,075 | 46,659 | 4,871 | 61,934 | |||||||||||||||||||||||||||||||||||||||
net income before income taxes | 69,293,000 | 71,286,000 | 74,181,000 | 57,205,000 | 55,788,000 | 29,089,000 | 46,707,000 | -38,021,000 | 48,512,000 | 37,313,000 | 33,008,000 | 26,007,000 | 28,245,000 | 17,459,000 | 12,813,000 | 14,072,000 | 15,900,000 | 9,882,000 | 8,723,664 | 11,737,271 | 10,393,159 | 11,035,980 | 8,405,370 | 14,238,567 | 11,409,599 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income tax provision | 17,185,000 | 14,549,000 | 14,994,000 | 5,814,000 | 10,750,000 | 7,745,000 | 3,525,750 | 3,259,000 | 6,626,000 | 4,218,000 | 7,454,856 | 7,454,856 | 5,072,559 | 5,072,559 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income | 52,108,000 | 56,737,000 | 55,936,000 | 43,884,000 | 40,794,000 | 23,275,000 | 34,844,000 | -30,764,000 | 37,762,000 | 29,568,000 | 25,471,000 | 22,748,000 | 21,619,000 | 13,241,000 | 9,309,000 | 10,329,000 | 12,181,000 | 7,663,000 | 11,437,131 | 43,339,867 | 9,779,987 | 10,426,015 | 7,929,713 | 13,630,179 | 10,959,948 | -644,503 | -14,499,609 | -7,838,873 | -5,965,140 | -5,699,892 | -5,387,698 | -4,177,649 | -3,879,901 | -4,967,129 | -4,163,320 | -3,953,981 | -4,568,914 | -5,386,237 | -5,815,158 | -4,449,038 | -4,558,503 | -5,410,259 | -3,490,030 | -5,009,892 | -3,198,020 | -3,811,119 | -43,533,661 | -5,912,059 | -3,143,590 | -1,744,289 | -38,179,202 | -2,621,535 | -289,080 | -1,089,186 | -34,063,489 | -1,127,841 | -1,394,151 | -1,517,136 | -28,433,986 | -903,985 | -1,328,541 | -1,045,043 | -21,625,424 | -1,286,720 | -1,761,887 | -3,031,201 | -3,747,750 | -16,715,554 | -13,860,194 | -11,482,754 | -16,715,554 | -944,938 | -8,953,769 | -8,219,422 | -7,011,292 | 46.96% | 46.96% | 4,762,028 | -5,017,973 | ||
yoy | 27.73% | 143.77% | 60.53% | -242.65% | 8.03% | -21.28% | 36.80% | -235.24% | 74.67% | 123.31% | 173.62% | 120.23% | 77.48% | 72.79% | -18.61% | -76.17% | 24.55% | -26.50% | 44.23% | 217.97% | -10.77% | -1717.68% | -154.69% | -273.88% | -283.73% | -88.69% | 169.12% | 87.64% | 53.74% | 14.75% | 29.41% | 5.66% | -15.08% | -7.78% | -28.41% | -11.13% | 0.23% | -0.44% | 66.62% | -11.19% | 42.54% | 41.96% | -91.98% | -15.26% | 1.73% | 118.49% | 14.02% | 125.52% | 987.45% | 60.15% | 12.08% | 132.44% | -79.26% | -28.21% | 19.80% | 24.76% | 4.94% | 45.17% | 31.48% | -29.75% | -24.60% | -65.52% | 477.02% | -92.30% | -87.29% | -73.60% | -77.58% | 1668.96% | 54.80% | 39.70% | 138.41% | -272.60% | 39.72% | ||||||||
qoq | -8.16% | 1.43% | 27.46% | 7.57% | 75.27% | -33.20% | -213.26% | -181.47% | 27.71% | 16.08% | 11.97% | 5.22% | 63.27% | 42.24% | -9.88% | -15.20% | 58.96% | -33.00% | -73.61% | 343.15% | -6.20% | 31.48% | -41.82% | 24.36% | -1800.53% | -95.56% | 84.97% | 31.41% | 4.65% | 5.79% | 28.96% | 7.67% | -21.89% | 19.31% | 5.29% | -13.46% | -15.17% | -7.38% | 30.71% | -2.40% | -15.74% | 55.02% | -30.34% | 56.66% | -16.09% | -91.25% | 636.35% | 88.07% | 80.22% | -95.43% | 1356.37% | 806.85% | -73.46% | -96.80% | 2920.24% | -19.10% | -8.11% | -94.66% | 3045.40% | -31.96% | 27.13% | -95.17% | 1580.66% | -26.97% | -41.87% | -19.12% | -77.58% | 20.60% | 20.70% | -31.30% | 1668.96% | -89.45% | 8.93% | 17.23% | -194.90% | ||||||
net income margin % | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income per share | -0.01 | -0.14 | -0.08 | -0.06 | -0.06 | -0.05 | -0.05 | -0.05 | -0.06 | -0.05 | -0.05 | -0.06 | -0.07 | -0.07 | -0.05 | -0.06 | -0.07 | -0.05 | -0.07 | -0.05 | -0.07 | -0.04 | -0.04 | -0.08 | -0.06 | -0.22 | 0.00% | 0.00% | 0.00% | 0.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||
basic | 0.43 | 0.47 | 0.46 | 0.37 | 0.35 | 0.2 | 0.33 | -0.29 | 0.36 | 0.28 | 0.24 | 0.22 | 0.21 | 0.13 | 0.09 | 0.1 | 0.12 | 0.07 | 0.11 | 0.42 | 0.09 | 0.1 | 0.08 | 0.13 | 0.11 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
diluted | 0.41 | 0.45 | 0.44 | 0.35 | 0.33 | 0.19 | 0.31 | -0.29 | 0.33 | 0.26 | 0.23 | 0.2 | 0.2 | 0.12 | 0.09 | 0.1 | 0.11 | 0.07 | 0.11 | 0.41 | 0.09 | 0.1 | 0.07 | 0.13 | 0.1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
weighted-average shares outstanding: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic | 122,163,212 | 121,472,468 | 118,457,673 | 118,931,153 | 118,180,396 | 116,806,117 | 106,279,736 | 106,568,137 | 106,258,790 | 105,561,229 | 103,374,606 | 103,318,572 | 102,795,600 | 102,781,771 | 103,379,349 | 103,196,550 | 103,407,803 | 103,814,725 | 103,512,913 | 103,535,431 | 103,414,523 | 103,407,347 | 102,944,316 | 102,974,105 | 102,869,202 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
diluted | 127,543,284 | 126,957,982 | 124,943,603 | 125,407,279 | 124,655,999 | 123,403,626 | 113,753,154 | 106,568,137 | 113,673,534 | 113,986,129 | 111,375,631 | 111,986,025 | 109,264,730 | 109,041,096 | 107,795,585 | 107,843,196 | 107,734,924 | 106,680,344 | 106,242,273 | 106,316,241 | 106,730,423 | 106,534,600 | 106,020,936 | 107,045,234 | 105,928,970 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other comprehensive income | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
unrealized gain on available-for-sale securities, net of tax of (15), 0, 10 and 4, respectively | 48 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
comprehensive income | 52,156 | 56,656 | 56,000 | 43,884 | 40,794 | 23,261 | 34,843 | -30,768 | 37,770 | 29,555 | 25,463 | 22,910 | 21,942 | 12,936 | 9,224 | 10,303 | 12,189 | 7,587 | 11,474,934 | 43,334,587 | 9,695,045 | 10,500,261 | 7,919,790 | 13,627,849 | 10,988,394 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
unrealized gain on available-for-sale securities, net of tax of 25 and 4, respectively | -81 | -7,011,292 | -7,011,292 | -5,017,973 | -5,017,973 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income tax benefit | 8,532,250 | 13,321,000 | 2,809,500 | -7,257,000 | 3,504,000 | 3,743,000 | -2,713,467 | -31,602,596 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
unrealized gain on available-for-sale securities, net of tax of 0, 1, 4 and 3, respectively | -3.5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
unrealized gain on available-for-sale securities, net of tax of 0, , 4 and 2, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
unrealized gain on available-for-sale securities, net of tax of 4 and 5, respectively | -14 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
unrealized gain on available-for-sale securities, net of tax of 1, (52), 3 and (59), respectively | -2.25 | -4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
unrealized gain on available-for-sale securities, net of tax of , (101), 2 and , respectively | 8 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other comprehensive income: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
unrealized gain on available-for-sale securities, net of tax of 5 and 94, respectively | -13 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
unrealized gain on available-for-sale securities, net of tax of (52), 0, (59) and 0, respectively | 45 | 162 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
unrealized gain on available-for-sale securities, net of tax of (101), 0, and 0, respectively | 323 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
unrealized gain on available-for-sale securities, net of tax of 94 and 0, respectively | -305 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
unrealized gain on available-for-sale securities | -23.5 | -26 | 8 | -76 | 37,803 | -5,280 | -84,942 | 74,246 | -9,923 | -2,330 | 28,446 | 13,560 | 25,700 | -9,450 | -14,672 | -21,826 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
benefit from income taxes | 3,719,000 | 2,219,000 | 613,172 | 609,965 | 475,657 | 608,388 | 449,651 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
revenues from collaborative arrangements | 182,186 | 150,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income from operations | -987,769 | -14,843,267 | -8,182,603 | -6,335,855 | -5,933,440 | -5,511,786 | -4,306,708 | -4,181,271 | -4,679,871 | -4,314,199 | -3,914,014 | -4,814,452 | -6,237,536 | -6,191,679 | -5,017,428 | -4,897,330 | -4,291,915 | -3,983,861 | -4,109,029 | -2,990,173 | -3,508,365 | -47,188,561 | -3,245,776 | -2,653,529 | -1,705,430 | -40,765,851 | -1,283,713 | -1,067,364 | -1,364,710 | -35,212,775 | -1,131,010 | -1,397,463 | -1,519,250 | -29,886,350 | -908,465 | -1,333,132 | -1,050,412 | -23,048,509 | -1,292,314 | -1,768,812 | -3,044,543 | -3,791,458 | -18,087,326 | -15,172,548 | -12,708,871 | -18,087,326 | -971,140 | -9,842,270 | -8,891,844 | -7,454,856 | 4,816,614 | -5,072,559 | |||||||||||||||||||||||||||||
income before income taxes | -644,503 | -14,499,609 | -7,838,873 | -5,965,140 | -5,699,892 | -5,387,698 | -4,177,649 | -3,879,901 | -4,967,129 | -4,163,320 | -3,953,981 | -4,568,914 | -5,386,237 | -5,815,158 | -4,449,038 | -4,558,503 | -5,410,259 | -3,490,030 | -5,009,892 | -3,198,020 | -3,811,119 | -43,533,661 | -5,912,059 | -3,143,590 | -1,744,289 | -38,179,202 | -2,621,535 | -289,080 | -1,089,186 | -34,063,489 | -1,127,841 | -1,394,151 | -1,517,136 | -28,433,986 | -903,985 | -1,328,541 | -1,045,043 | -21,625,424 | -1,286,720 | -1,761,887 | -3,031,201 | -3,747,750 | -16,715,554 | -13,860,194 | -11,482,754 | -16,715,554 | -944,938 | -8,953,769 | -8,219,422 | -7,011,292 | 4,762,028 | -5,017,973 | |||||||||||||||||||||||||||||
net income per share | -0.01 | -0.14 | -0.08 | -0.06 | -0.06 | -0.05 | -0.05 | -0.05 | -0.06 | -0.05 | -0.05 | -0.06 | -0.07 | -0.07 | -0.05 | -0.06 | -0.07 | -0.05 | -0.07 | -0.05 | -0.07 | -0.04 | -0.04 | -0.08 | -0.06 | -0.22 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
weighted-average shares outstanding – basic and diluted | 102,747,923 | 102,633,884 | 102,641,504 | 102,596,446 | 102,557,350 | 85,802,487 | 84,797,969 | 83,905,827 | 82,972,316 | 82,875,281 | 82,870,649 | 82,870,649 | 82,860,083 | 80,858,393 | 82,470,139 | 82,037,560 | 76,039,220 | 64,142,534 | 67,169,383 | 66,167,556 | 54,138,580 | 44,686,310 | 41,445,413 | 41,420,687 | 32,132,824 | 26,851,410 | 24,710,362 | 21,654,680 | 21,654,680 | 19,922,057 | 18,821,881 | 18,043,385 | 18,043,385 | 14,065,385 | 14,065,385 | ||||||||||||||||||||||||||||||||||||||||||||||
other comprehensive loss: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
comprehensive loss | -630,943 | -14,473,909 | -7,848,323 | -5,979,812 | -5,721,718 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
general and administrative | 6,926,298 | 3,644,234 | 2,631,031 | 2,674,398 | 2,107,152 | 1,601,785 | 1,729,520 | 1,865,942 | 1,493,545 | 1,420,015 | 2,305,555 | 2,691,145 | 2,360,068 | 1,974,757 | 2,319,822 | 1,942,363 | 1,599,620 | 1,223,137 | 891,215 | 759,682 | 17,306,131 | 441,424 | 521,491 | 613,129 | 14,866,409 | 628,876 | 534,623 | 637,383 | 12,481,750 | 516,873 | 491,828 | 615,297 | 9,853,178 | 408,374 | 535,197 | 610,825 | 7,645,430 | 441,316 | 392,559 | 721,911 | 519,099 | 6,504,163 | 6,040,964 | 5,479,431 | 6,504,163 | 420,558 | 4,469,200 | 4,022,122 | 3,587,914 | -2,038,411 | 2,156,676 | ||||||||||||||||||||||||||||||
change in fair value of warrants liability | 210,331 | -397,235 | 106,946 | -106,948 | 152,783 | 733,356 | 389,596 | 521,731 | 333,956 | -1,180,278 | 472,026 | -906,787 | -223,591 | -335,514 | 2,140,025 | -2,676,601 | -498,587 | -45,326 | 1,099,310 | -1,340,566 | 776,919 | 274,207 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
revenues | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
interest income | 13,607 | 5,924 | 15,744 | 32,760 | 1,514,875 | 10,318 | 8,526 | 6,467 | 1,487,339 | 2,744 | 1,365 | 1,317 | 1,469,194 | 3,169 | 3,312 | 2,114 | 1,452,364 | 4,480 | 4,591 | 5,369 | 1,423,085 | 5,594 | 6,925 | 13,342 | 43,708 | 1,371,772 | 1,312,354 | 1,226,117 | 1,371,772 | 197,631 | 888,501 | 672,422 | 443,564 | 13,646.5 | 54,586 | ||||||||||||||||||||||||||||||||||||||||||||||
revenues – government grant | -7,454,856 | -7,454,856 | -5,072,559 | -5,072,559 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
revenues - government grant | -7,011,292 | -7,011,292 | -5,017,973 | -5,017,973 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss per share – basic and diluted | -0.063 | -0.13 | -0.08 | -0.035 | -0.08 | -0.01 | -0.048 | -0.05 | -0.06 | -0.045 | -0.05 | -0.07 | -0.108 | -0.09 | -0.13 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
revenues—government grant | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
weighted-average shares outstanding—basic and diluted | 14,065,329 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss per share — basic and diluted | -0.065 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
weighted-average shares outstanding — basic and diluted | 3,587,914 | 3,587,914 | 2,156,676 | 2,156,676 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
We provide you with 20 years income statements for Catalyst Pharmaceuticals stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Catalyst Pharmaceuticals stock. Explore the full financial landscape of Catalyst Pharmaceuticals stock with our expertly curated income statements.
The information provided in this report about Catalyst Pharmaceuticals stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.